Repligen Corporation
Save
8.24B
Market cap
–
Current P/E
113.64x
Forward P/E
About
Health care
Sector
Medical - Instruments & Supplies
Industry
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes.
Similar securities
Based on sector and market capitalization
Report issue